These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 3005438
1. Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. Kitchen L, Malone G, Orgad S, Barin F, Zaizov R, Ramot B, Gazit E, Kreiss J, Leal M, Wichmann I. J Infect Dis; 1986 Apr; 153(4):788-90. PubMed ID: 3005438 [No Abstract] [Full Text] [Related]
2. Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs. Kloster BE, Tomar RH, Stockman JA, Lamberson HV, Merl SA, John PA, Groth DM, Poiesz BJ. Am J Clin Pathol; 1985 Apr; 83(4):450-6. PubMed ID: 2984918 [Abstract] [Full Text] [Related]
3. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Erfle V, Hehlmann R, Heimpel H. Klin Wochenschr; 1986 Feb 03; 64(3):115-24. PubMed ID: 3005759 [Abstract] [Full Text] [Related]
4. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV). Barin F, Denis F, Baillou A, Leonard G, Mounier M, M'Boup S, Gershy-Damet G, Sangare A, Kanki P, Essex M. J Virol Methods; 1987 Aug 03; 17(1-2):55-61. PubMed ID: 2444614 [Abstract] [Full Text] [Related]
7. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs]. Muncunill J, Forteza A, Forner N, Forteza-Rei J. Med Clin (Barc); 1986 Apr 05; 86(13):565. PubMed ID: 3012224 [No Abstract] [Full Text] [Related]
9. Abnormality of helper/suppressor T cell ratio in patients with hemophilia. Yasuda K, Matsumoto K, Okubo K, Yokoyama MM, Hiyoshi Y, Natori H. J Clin Lab Immunol; 1985 Jan 05; 16(1):27-30. PubMed ID: 2984427 [Abstract] [Full Text] [Related]
14. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986. Garsia RJ, Gatenby PA, Basten A, Kenny DF, Gallagher KJ, Rickard KA, Gust ID, Maskill W. Aust N Z J Med; 1987 Aug 05; 17(4):371-8. PubMed ID: 2963611 [Abstract] [Full Text] [Related]
15. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects. Manca N, di Marzo Veronese F, Ho DD, Gallo RC, Sarngadharan MG. Eur J Epidemiol; 1987 Jun 05; 3(2):96-102. PubMed ID: 3497054 [Abstract] [Full Text] [Related]
16. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Barin F, McLane MF, Allan JS, Lee TH, Groopman JE, Essex M. Science; 1985 May 31; 228(4703):1094-6. PubMed ID: 2986291 [Abstract] [Full Text] [Related]
20. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, Haseltine WA, Lee TH, Essex M. Science; 1985 May 31; 228(4703):1091-4. PubMed ID: 2986290 [Abstract] [Full Text] [Related] Page: [Next] [New Search]